- Generic name
- Rabeprazole Sodium
- Strength
- 20 mg
- Dosage form
- Tablet
- Manufactured by
- MST Pharma and Healthcare Ltd.
Rabitop 20 Tablet
About Rabitop 20 Tablet
Rabitop 20 is a 20 mg tablet made by MST Pharma and Healthcare Ltd. Its generic is Rabeprazole Sodium, a proton pump inhibitor that reduces the amount of acid the stomach produces.
There are 48 brands of Rabeprazole Sodium listed in Bangladesh. The lowest listed price is Acifix 10 mg Sprinkle Capsule at ৳ 3.50 per unit.
What is Rabitop 20 Tablet?
Rabitop 20 is a tablet containing 20 mg of Rabeprazole Sodium. It belongs to a group of medicines called proton pump inhibitors. These medicines work by blocking the acid pump in the stomach, which lowers the amount of acid produced. Rabeprazole tablets are used in adults for conditions linked to too much stomach acid, such as active duodenal ulcer, active benign gastric ulcer and gastro-esophageal reflux disease, including long-term management of reflux disease. The doctor decides the dose, the course and how long you take it.
Uses of Rabitop 20
Rabitop 20 is used to treat active duodenal ulcer and active benign gastric ulcer. It is also used for symptomatic erosive or ulcerative gastro-esophageal reflux disease, often called GERD, and for long-term management of GERD. It can be used for the symptomatic treatment of moderate to very severe GERD. Your doctor will confirm whether it suits your condition and decide the dose and course.
How to use Rabitop 20
Take Rabitop 20 as your doctor tells you. The doctor decides the dose, when to take it and how long the course lasts; ask your pharmacist for clear instructions if anything is unclear. Do not change the dose or stop early on your own, even if you feel better. Tell your doctor about all other medicines you take, because some medicines, including certain antifungals and atazanavir, may interact with it.
Side effects of Rabitop 20
Rabitop 20 is generally well tolerated. Some people may get a headache, diarrhoea, abdominal pain, vomiting or constipation. Dry mouth, increased or decreased appetite, muscle pain, drowsiness and dizziness can also occur. Contact your doctor if a side effect is severe, does not settle, or worries you, and seek urgent help for any serious reaction. Your doctor or pharmacist can advise on what to watch for.
Safety and precautions
Do not take Rabitop 20 if you are allergic to rabeprazole or any ingredient in the tablet. It is not to be used during pregnancy or breastfeeding. Tell your doctor before starting if you are pregnant, could be pregnant or are nursing. A response to treatment does not rule out stomach or oesophageal cancer, so the doctor should exclude this before treatment begins. People on long-term treatment need regular check-ups, and long-term high-dose use may raise fracture risk, especially in older people.
Frequently asked questions
What kind of medicine is Rabitop 20 and what is it used for?
It is a proton pump inhibitor containing 20 mg Rabeprazole Sodium. It is used for active duodenal ulcer, active benign gastric ulcer and gastro-esophageal reflux disease, including long-term management. Your doctor will confirm if it is right for your condition.
Who should avoid Rabitop 20 or ask the doctor first?
Do not use it if you are allergic to rabeprazole or any ingredient. It is not to be used in pregnancy or breastfeeding. Tell your doctor about pregnancy, nursing, other medicines and any long-term health problems before starting.
What side effects should I watch for?
Headache, diarrhoea, abdominal pain, vomiting, constipation, dry mouth, appetite changes, muscle pain, drowsiness and dizziness can occur. Contact your doctor if a side effect is severe or does not settle, and get urgent help for any serious reaction.
How should I store Rabitop 20?
Keep the tablets below 30°C, away from light and moisture, and out of the reach of children. Ask your pharmacist if you are unsure how to store or dispose of unused tablets.
Indications
- Active duodenal ulcer
- Active benign gastric ulcer
- Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
- Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance) ... Read more
- Active duodenal ulcer
- Active benign gastric ulcer
- Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
- Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
- Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
- Zollinger-Ellison Syndrome
- In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.
Pharmacology
Dosage & Administration
Erosive or Ulcerative Gastro-Esophageal Reflux Disease (GERD): The recommended oral dose for this condition is 20 mg to be taken once daily for four to eight weeks.
Gastro-Esophageal Reflux Disease Long-term Management (GERD Maintenance): For long-term management, a maintenance dose of rabeprazole sodium 20 mg or 10 mg once daily can be used depending upon patient response.
Symptomatic treatment of moderate to very severe Gastro-Esophageal Reflux Disease (symptomatic GERD): 10 mg once daily in patients without oesophagitis. If symptom control has not been achieved during four weeks, the patient should be further investigated. Once symptoms have resolved, subsequent symptom control can be achieved using an on-demand regimen taking 10 mg once daily when needed.
Treatment of GERD in pediatric patients 1 to 11 years of age (Less than 15 kg): 5 mg once daily for 12 weeks with the option to increase to 10 mg if inadequate response.
Treatment of GERD in pediatric patients 1 to 11 years of age (15 kg or more): 10 mg once daily for 12 weeks.
Zollinger-Ellison Syndrome: The recommended adult starting dose is 60 mg once a day. The dose may be titrated upwards to 120 mg/day based on individual patient needs. Single daily doses up to 100 mg/day may be given. 120 mg dose may require divided doses, 60 mg twice daily. Treatment should continue for as long as clinically indicated.
Eradication of H. pylori: Patients with H. pylori infection should be treated with eradication therapy. The following combination given for 7 days is recommended. Rabeprazole sodium 20 mg twice daily, clarithromycin 500 mg twice daily and amoxicillin 1g twice daily.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
- Symptomatic response to therapy with Rabeprazole does not preclude the presence of gastric or oesophageal malignancy, therefore the possibility of malignancy should be excluded prior to commencing treatment with Rabeprazole 20 mg Gastro-resistant Tablets.
- Patients on long-term treatment (particularly those treated for more than a year) should be kept under regular surveillance.
- Proton pump inhibitors, especially if used in high doses and over long durations (>1 year), may modestly increase the risk of hip, wrist and spine fracture, predominantly in the elderly or in presence of other recognised risk factors. Observational studies suggest that proton pump inhibitors may increase the overall risk of fracture by 10–40%. Some of this increase may be due to other risk factors. Patients at risk of osteoporosis should receive care and they should have an adequate intake of vitamin D and calcium.
- A risk of cross-hypersensitivity reactions with other proton pump inhibitor or substituted benzimidazoles cannot be excluded.
- Patients should be cautioned that Rabeprazole gastro-resistant tablets should not be chewed or crushed, but should be swallowed whole.
- There have been post marketing reports of blood dyscrasias (thrombocytopenia and neutropenia). In the majority of cases where an alternative aetiology cannot be identified, the events were uncomplicated and resolved on discontinuation of rabeprazole.
- Hepatic enzyme abnormalities have been seen in clinical trials and have also been reported since market authorisation. In the majority of cases where an alternative aetiology cannot be identified, the events were uncomplicated and resolved on discontinuation of rabeprazole.
- No evidence of significant drug related safety problems was seen in a study of patients with mild to moderate hepatic impairment versus normal age and sex matched controls. However because there are no clinical data on the use of rabeprazole in the treatment of patients with severe hepatic dysfunction the prescriber is advised to exercise caution when treatment with Rabeprazole 20mg Gastro-resistant. Tablets is first initiated in such patients.
- Co-administration of atazanavir with Rabeprazole is not recommended.
- Treatment with proton pump inhibitors, including rabeprazole, may possibly increase the risk of gastrointestinal infections such as Salmonella, Campylobacter and Clostridium difficile.
Influence on vitamin B12 absorption: Rabeprazole sodium, as all acid-blocking medicines, may reduce the absorption of vitamin B12 (cyanocobalamin) due to hypo- or a- chlorhydria. This should be considered in patients with reduced body stores or risk factors for reduced vitamin B12 absorption on long-term therapy or if respective clinical symptoms are observed.
Subacute cutaneous lupus erythematosus (SCLE): Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping Rabeprazole. SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors.
Interference with laboratory tests: Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours. To avoid this interference, Rabeprazole 20mg Gastro-resistant Tablets treatment should be stopped for at least 5 days before CgA measurements. If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of proton pump inhibitor treatment.
Overdose Effects
Storage Conditions
Alternative brands of Rabeprazole Sodium
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.